One-Stop Gene Editing Platform
Full-process services covering gene editing tools, delivery, evaluation and model construction
Gene Editing Tool Development
We offer comprehensive solutions for the development and validation of novel CRISPR systems
Gene Editing Delivery Platform
We provide a full-service system for gene editing delivery vectors from design to validation.
Gene Editing Evaluation System
We offer integrated in vitro and in vivo services to evaluate the efficacy and safety of gene editing therapies.
Gene Editing Model Development
We provide construction services for various gene-edited models, including cells, microorganisms, etc.
Supply of Molecular Diagnostic Reagents
High-performance Domestic Self-developed Raw Materials
  • Universal CAR-T Full-Process Safety Assessment Solutions
  • iPSC Gene Editing and Quality Control Solution
  • In Vivo Gene Therapy Solution
  • Base EdiBase Editing (ABE/CBE) ) Solutioning Solution 补充说明：碱基编辑（
  • Molecular Diagnostic Raw Material Solution
Universal CAR-T Full-Process Safety Assessment Solutions
We provide one-stop services ranging from sgRNA design, high-efficiency and low-off-target editing to comprehensive safety assessments compliant with IND requirements (including off-target, chromosomal translocation, and integration site analysis), accelerating the R&D and application of universal CAR-T products.
iPSC Gene Editing and Quality Control Solution
We provide a complete iPSC gene editing solution covering RNP delivery, monoclonal screening, and whole-genome safety quality control, ensuring strict compliance with clinical-grade application requirements and high-standard delivery.
In Vivo Gene Therapy Solution
We provide a complete solution centered on safer MiniCircle plasmids and targeted LNP delivery, combined with comprehensive in vivo safety assessments including off-target effects, integration analysis and biodistribution testing, to facilitate the efficient development of in vivo gene therapy products.
Base Editing（ABE/CBE）Solution
We offer an exclusive multi-dimensional safety assessment tailored for CBE/ABE, covering DNA off-target effects, genome-wide random mutations and RNA off-target effects. With our self-developed Detect-seq/Ino-seq technologies, we guarantee the comprehensiveness and reliability of base editing therapeutics.
Molecular Diagnostic Raw Material Solution
From core Tn5 transposase raw materials and epigenetics technical services, to NGS library preparation kits and key hybridization capture consumables — GeneRulor provides efficient, precise and professional complete solutions for global life science research and clinical diagnosis.
Next-Gen Microbial Gene Editing Platform
— Breaking through the limitations of traditional strain engineering, empowering industrial‑scale precise editing and large‑scale applications of microorganisms.
Tel：+86 15336557985
E-Mail：service@generulor.com
Micromessenger
Scan to consult
Linkedin
LIN HUABING
Teams：15022705442@163.com